Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Attilio Di Girolamo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Dermatology|March 26, 2026
Steroid-Modified Scabies: Quantifying a Clinically Recognized but Understudied ProblemAttilio Di Girolamo, Mattia Cristallo
European Journal of Clinical Investigation|October 10, 2024
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta-analysis of eight studiesFederico Spataro, Antonio Giovanni Solimando, Attilio Di Girolamo, et al.
Journal of Infection in Developing Countries|February 20, 2025
Acyclovir desensitization. A case report and a review of desensitization strategiesFederico Spataro, Roberto Ria, Nada Choul, et al.
Acta Haematologica|March 18, 2020
Desensitization in Iron Product AllergyAttilio Di Girolamo, Marcello Albanesi, Filomena Loconte, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 15, 2026
Dupilumab in the treatment of severe chronic rhinosinusitis with nasal polyps (CRSwNP) in cystic fibrosis patientsAttilio Di Girolamo, Mattia Cristallo, Michelina Francesca Daddato, et al.
Clinical and Molecular Allergy : CMA|November 3, 2018
Rapid desensitization for brentuximab vedotin (Adceteris<sup>®</sup>) allergy: a case reportAttilio Di Girolamo, Marcello Albanesi, Alessandro Sinisi, et al.
Orphanet Journal of Rare Diseases|December 28, 2024
Two-year follow-up after drug desensitization in mucopolysaccharidosisFederico Spataro, Roberto Ria, Nada Chaoul, et al.
The Journal of Allergy and Clinical Immunology. Global|March 4, 2026
Response to venom immunotherapy: Exploratory retrospective machine learning clustering analysisStefano Palazzo, Marcello Albanesi, Mattia Cristallo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Dermatology|March 26, 2026
Steroid-Modified Scabies: Quantifying a Clinically Recognized but Understudied ProblemAttilio Di Girolamo, Mattia Cristallo
European Journal of Clinical Investigation|October 10, 2024
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta-analysis of eight studiesFederico Spataro, Antonio Giovanni Solimando, Attilio Di Girolamo, et al.
Journal of Infection in Developing Countries|February 20, 2025
Acyclovir desensitization. A case report and a review of desensitization strategiesFederico Spataro, Roberto Ria, Nada Choul, et al.
Acta Haematologica|March 18, 2020
Desensitization in Iron Product AllergyAttilio Di Girolamo, Marcello Albanesi, Filomena Loconte, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 15, 2026
Dupilumab in the treatment of severe chronic rhinosinusitis with nasal polyps (CRSwNP) in cystic fibrosis patientsAttilio Di Girolamo, Mattia Cristallo, Michelina Francesca Daddato, et al.
Clinical and Molecular Allergy : CMA|November 3, 2018
Rapid desensitization for brentuximab vedotin (Adceteris<sup>®</sup>) allergy: a case reportAttilio Di Girolamo, Marcello Albanesi, Alessandro Sinisi, et al.
Orphanet Journal of Rare Diseases|December 28, 2024
Two-year follow-up after drug desensitization in mucopolysaccharidosisFederico Spataro, Roberto Ria, Nada Chaoul, et al.
The Journal of Allergy and Clinical Immunology. Global|March 4, 2026
Response to venom immunotherapy: Exploratory retrospective machine learning clustering analysisStefano Palazzo, Marcello Albanesi, Mattia Cristallo, et al.
Pageof 1